Skip to main content

. 1939 Sep;18(5):507–519. doi: 10.1172/JCI101064

THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY

J S Harris ^1,², H O Michel ^1,²

PMCID: PMC434896 PMID: 16694682

507

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bensley E. H., Ross J. B. Methaemoglobinaemia due to Sulphanilamide Therapy. Can Med Assoc J. 1937 Jul;37(1):62–64. [PMC free article] [PubMed] [Google Scholar]
Chesley L. C. CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT. J Clin Invest. 1938 Jul;17(4):445–447. doi: 10.1172/JCI100971. [DOI] [PMC free article] [PubMed] [Google Scholar]
Clarke T. W., Hurtley W. H. On sulphhaemoglobin. J Physiol. 1907 Aug 27;36(1):62–67. doi: 10.1113/jphysiol.1907.sp001217. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hartmann A. F., Perley A. M., Barnett H. L. A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL. J Clin Invest. 1938 Nov;17(6):699–710. doi: 10.1172/JCI100997. [DOI] [PMC free article] [PubMed] [Google Scholar]
Long P. H., Bliss E. A. TOXIC MANIFESTATIONS OF SULFANILAMIDE. Ann Surg. 1938 Nov;108(5):808–812. doi: 10.1097/00000658-193811000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES